Cambridge: AstraZeneca s Soliris (eculizumab) has been approved in Japan for expanded use to include the treatment of generalised myasthenia gravis (gMG) in paediatric patients who are.
Soliris approved in Japan for paediatric patients with generalised myasthenia gravis (gMG) nationaltribune.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nationaltribune.com.au Daily Mail and Mail on Sunday newspapers.
Japan Approves Soliris for Paediatric gMG Patients miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca PLC on Thursday said both its Soliris and Lynparza treatments have been approved in Japan.
The Cambridge-based pharmaceutical company said Soliris received approval for the treatment of.